Motavizumab Biosimilar - Research Grade

Human

RSV

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human RSV

Blue ice

The respiratory syncytial virus (RSV) fusion glycoprotein mediates viral entry into host cells and is a primary antigen in antiviral and vaccine research. This research-grade anti-RSV recombinant monoclonal is an unconjugated, non-therapeutic analog of motavizumab, supplied for research use only (RUO). It is made to rigorous in vivo specifications, carries a low-endotoxin profile, and is available in scalable milligram (mg) to gram (g) quantities to meet bulk and high-throughput demand. Suitable applications include functional assays, neutralisation and fusion-protein-binding studies, reference controls, and in vivo models of RSV infection where reproducible, well-defined reagents are required.

ICH3002

https://www.imgt.org/mAb-DB/